Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabiola Moretti

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Molecular & Cellular Oncology|June 17, 2016
Novel insights about the MDM2/MDM4 heterodimerFabiola Moretti
Cell Cycle (Georgetown, Tex.)|November 6, 2009
Mitochondrial MDM4 (MDMX): an unpredicted role in the p53-mediated intrinsic apoptotic pathwayFrancesca Mancini, Fabiola Moretti
Biochemistry and Biophysics Reports|February 9, 2026
A workflow for quantifying cell quiescence in 3D spheroidsMaria Rita Assenza, Federica Barbagallo, Fabiola Moretti
Frontiers in Oncology|July 26, 2021
Role of Sex in the Therapeutic Targeting of p53 CircuitryFrancesca Mancini, Ludovica Giorgini, Emanuela Teveroni, et al.
International Journal of Nanomedicine|September 14, 2016
MDM2-MDM4 molecular interaction investigated by atomic force spectroscopy and surface plasmon resonanceIlaria Moscetti, Emanuela Teveroni, Fabiola Moretti, et al.
Expert Opinion on Therapeutic Patents|September 8, 2016
Peptides and peptidomimetics in the p53/MDM2/MDM4 circuitry - a patent reviewEmanuela Teveroni, Rossella Lucà, Marsha Pellegrino, et al.
Bioorganic & Medicinal Chemistry|October 6, 2024
Rational design, synthesis, and biophysical characterization of a peptidic MDM2-MDM4 interaction inhibitorMarco Ballarotto, Elisa Bianconi, Sonia Valentini, et al.
Expert Opinion on Therapeutic Patents|February 24, 2011
Alternative strategies for targeting mouse double minute 2 activity with small molecules: novel patents on the horizon?Antonio Macchiarulo, Nicola Giacchè, Francesca Mancini, et al.
Cell Cycle (Georgetown, Tex.)|March 1, 2012
MDM4 enhances p53 stability by promoting an active conformation of the protein upon DNA damageGiusy Di Conza, Francesca Mancini, Marianna Buttarelli, et al.
Molecular Cell|March 14, 2007
MDM2-regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damage-induced apoptosisCinzia Rinaldo, Andrea Prodosmo, Francesca Mancini, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Molecular & Cellular Oncology|June 17, 2016
Novel insights about the MDM2/MDM4 heterodimerFabiola Moretti
Cell Cycle (Georgetown, Tex.)|November 6, 2009
Mitochondrial MDM4 (MDMX): an unpredicted role in the p53-mediated intrinsic apoptotic pathwayFrancesca Mancini, Fabiola Moretti
Biochemistry and Biophysics Reports|February 9, 2026
A workflow for quantifying cell quiescence in 3D spheroidsMaria Rita Assenza, Federica Barbagallo, Fabiola Moretti
Frontiers in Oncology|July 26, 2021
Role of Sex in the Therapeutic Targeting of p53 CircuitryFrancesca Mancini, Ludovica Giorgini, Emanuela Teveroni, et al.
International Journal of Nanomedicine|September 14, 2016
MDM2-MDM4 molecular interaction investigated by atomic force spectroscopy and surface plasmon resonanceIlaria Moscetti, Emanuela Teveroni, Fabiola Moretti, et al.
Expert Opinion on Therapeutic Patents|September 8, 2016
Peptides and peptidomimetics in the p53/MDM2/MDM4 circuitry - a patent reviewEmanuela Teveroni, Rossella Lucà, Marsha Pellegrino, et al.
Bioorganic & Medicinal Chemistry|October 6, 2024
Rational design, synthesis, and biophysical characterization of a peptidic MDM2-MDM4 interaction inhibitorMarco Ballarotto, Elisa Bianconi, Sonia Valentini, et al.
Expert Opinion on Therapeutic Patents|February 24, 2011
Alternative strategies for targeting mouse double minute 2 activity with small molecules: novel patents on the horizon?Antonio Macchiarulo, Nicola Giacchè, Francesca Mancini, et al.
Cell Cycle (Georgetown, Tex.)|March 1, 2012
MDM4 enhances p53 stability by promoting an active conformation of the protein upon DNA damageGiusy Di Conza, Francesca Mancini, Marianna Buttarelli, et al.
Molecular Cell|March 14, 2007
MDM2-regulated degradation of HIPK2 prevents p53Ser46 phosphorylation and DNA damage-induced apoptosisCinzia Rinaldo, Andrea Prodosmo, Francesca Mancini, et al.
Pageof 5